Clinical Outcomes of Implementing Evidence-Based Practice on Venous Thromboembolism Prevention for Cancer Patients In Qatar, A Retrospective Study

Elazzazy, Shereen; Wahab, Romina; Negm, Reham; Wahid,; Yafei, Sumaya Al; Zaidan, Manal; Hijji, Ibrahim Al

doi:10.1016/j.clinthera.2015.05.071

Cited by 1 publication

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…NCCCR's VTE prophylaxis guidelines addressed the most important clinical issues regarding thromboprophylaxis in the inpatient and the outpatient settings. Since implementation of this protocol in the inpatient setting, the incidence of VTE during admission was significantly reduced by 66.4% (P=0.0145) [23]. Yet, this was not the situation in the ambulatory setting.…”

Section: Introductionmentioning

confidence: 95%

Assessment of Deep Vein Thrombosis (DVT) incidence among ambulatory cancer patients in Qatar: A retrospective cohort study

Abdelwahab¹,

Hamad²,

Negm³

et al. 2021

GSC Biol. and Pharm. Sci.

View full text Add to dashboard Cite

Background: Thromboprophylaxis of ambulatory cancer patients is considered controversial. However, some guidelines suggest conducting VTE risk assessment using the Khorana risk assessment scoring model. This study aims to assess the incidence of Deep Vein Thrombosis (DVT) and related cancer types, focusing on the incidence of DVT in ambulatory patients actively on chemotherapy, with Khorana risk score (KRS). Methods: The Doppler ultrasound reports over 12-month period were reviewed. A total of 205 patients were included in the study. Patients with DVT were screened for the relevant biomarkers in KRS model and any other additional risk factors. Furthermore, a comparison between ambulatory patients who developed DVT and those who did not, was carried on determining the KRS association with incidence. Results: The incidence of DVT in ambulatory cancer patients was higher than the inpatient setting (23% vs. 8%). Breast cancer was the most common malignancy associated with DVT (30%) followed by colon cancer (17%). Chemotherapy increased the incidence of DVT in ambulatory patients (29% vs. 13%). Patients with KRS of ≥2 were more likely to develop DVT (37.5%). Conclusion: This study highlights the importance of conducting a thorough DVT risk assessment for ambulatory cancer patients on chemotherapy and the need to look for KRS to reconsider additional risk factors.

show abstract

Section: Introductionmentioning

confidence: 95%